8.06 USD
▲+0.07+2.41%
盘后 7.89 +0.25%
2026-08-03
市值
$236.82M
市盈率
—
EPS
-5.79
股息率
—
52 周区间
5.60 – 12.57
成交量
297.96K
Beta
0.61
目标价
34.57
52W 低 5.6052W 高 12.57
价格走势
公司简介
Cartesian Therapeutics, Inc., a clinical-stage biotechnology company, provides mRNA cell therapies for the treatment of autoimmune diseases. The company’s lead product candidate is Descartes-08, an autologous mRNA chimeric antigen receptor T-cell cell therapy (CAR-T) directed against the B cell maturation antigen (BCMA), which is in Phase 2b clinical trials for the treatment of autoimmune diseases, generalized myasthenia gravis, and systemic lupus erythematosus, as well as rare pediatric disease designation for the treatment of juvenile dermato...